Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
J.P. Morgan Healthcare Conference
Pharma
Ionis doubles its sales projection for Tryngolza in sHTG to $2B
As Ionis prepares to roll Tryngolza out in a new indication, it has doubled its peak sales projection for the therapy in severe hypertriglyceridemia.
Kevin Dunleavy
Jan 13, 2026 3:45pm
Recapping the 2025 J.P. Morgan Healthcare Conference
Jan 24, 2025 9:00am
Bigger M&A deals to come in 2025 after 'reset' year: reports
Jan 13, 2025 9:06am
Bayer projects $3B sales potential each for Kerendia, Nubeqa
Jan 10, 2023 4:20pm
Takeda expands manufacturing in preparation for Qdenga launch
Jan 10, 2023 10:17am
Eylea sales disappoint in Q4, Regeneron says its a 'blip'
Jan 9, 2023 3:15pm
